🇺🇸 FDA
Patent

US 11701421

Compositions and methods for stabilizing flaviviruses with improved formulations

granted A61KA61K2039/5254A61K2039/55505

Quick answer

US patent 11701421 (Compositions and methods for stabilizing flaviviruses with improved formulations) held by Takeda Vaccines, Inc. expires Mon Jul 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Vaccines, Inc.
Grant date
Tue Jul 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61K, A61K2039/5254, A61K2039/55505, A61K2039/55511, A61K2039/55516